Chao Li

Ms. Chao Li


Research Focus & Metrics

Academic Career Length

12Years (2015-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
27 July 2015 in Molecules
Verified
Journal Article
Open access
PDF file
CLChao Li
Chao Li
KJKun Jiang
Kun Jiang
YCYing-Chun Chen
Ying-Chun Chen
An asymmetric annulation reaction of γ-butenolides and cyclic 1-azadienes containing a 1,2-benzoisothiazole-1,1-dioxide motif has been studied, proceeding in a tandem Michael addition-aza-Michael addition sequence. Endo-type cycloadducts bearing fused tetracyclic skeletons were isolated in fair yields and with high enantioselectivity (up to >99% ee) under the catalysis of modified cinchona alkaloid (DHQD)2PHAL. Besides, exo-type diastereomers could be produced using β-isocupreidine (β-ICD) as the catalyst, though with moderate enantioselectivity.

22 June 2022 in Pharmaceutics
Verified
Journal Article
Open access
PDF file
CLChunming Li
Chunming Li
TZTengyue Zhao
Tengyue Zhao
LLLixian Li
Lixian Li
GHGang Xiao Hu
Gang Xiao Hu
CLChao Li
Chao Li
YHYurong Hu
Yurong Hu
With advances in nanotechnology, various new drug delivery systems (DDSs) have emerged and played a key role in the diagnosis and treatment of cancers. Over the last two decades, gold nanocages (AuNCs) have been attracting considerable attention because of their outstanding properties. This review summarizes current advancements in endogenous, exogenous, and dual/multi-stimuli responsive AuNCs in drug delivery. This review focuses on the properties, clinical translation potential, and limitations of stimuli-responsive AuNCs for cancer diagnosis and treatment.

26 August 2025 in Frontiers in Pharmacology
Verified
Journal Article
Open access
PDF file
QZQiongyin Zhang
Qiongyin Zhang
NLNa Li
Na Li
XMXue Ma
Xue Ma
YQYue Qiu
Yue Qiu
CLChao Li
Chao Li
YCYa Chen
Ya Chen
Background: Gefitinib (GEF), a first-generation epidermal growth factor receptor (EGFR) tyrosine kinase inhibitor (TKI) for non-small cell lung cancer (NSCLC), is frequently associated with drug-induced liver injury (DILI), thereby limiting its clinical application. This study aimed to evaluate the hepatoprotective effects of berberine (BBR) and explore the underlying mechanisms.Methods: In vitro, human hepatocyte lines (THLE-2 and THLE-3) were exposed to GEF alone or in combination with HMGB1 siRNA, a TLR4 inhibitor, an NF-κB inhibitor, or varying concentrations of BBR to assess hepatotoxicity and the involvement of the HMGB1/TLR4/NF-κB pathway. In vivo, Sprague-Dawley (SD) rats were treated with GEF with or without different doses of BBR for 21 days. Liver injury and inflammatory responses were assessed, and pathway alterations were evaluated at both transcriptional and protein levels.Results: GEF activated the HMGB1/TLR4/NF-κB pathway in vitro, increasing the levels of p-NF-κB p65, ALT, AST, and pro-inflammatory cytokines (INF-α, IL-1β and IL-6). BBR inhibited these effects in a concentration-dependent manner by suppressing pathway activation, reducing hepatotoxicity, and inhibiting HMGB1 nuclear-to-cytoplasmic translocation. In vivo, GEF induced weight loss, an increased liver-to-body weight ratio, elevated serum transaminases and pro-inflammatory cytokines, and histopathological liver injury, all of which were dose-dependently ameliorated by BBR co-administration. Moreover, BBR significantly downregulated the expression of HMGB1, TLR4, and NF-κB at both mRNA and protein levels in liver tissues.Conclusion: GEF-induced liver injury is mediated by HMGB1-driven inflammation via the TLR4/NF-κB pathway. BBR provides dose-dependent hepatoprotection by targeting this pathway, suggesting a potential strategy to protect against GEF-induced liver injury among NSCLC patients.

17 March 2025 in International Journal of Clinical Pharmacy
Verified
Journal Article
Closed access
PDF file
XHXiaogang Hu
Xiaogang Hu
YCYa Chen
Ya Chen
YTYuelu Tang
Yuelu Tang
XWXiaoxiao Wang
Xiaoxiao Wang
LLLixian Li
Lixian Li
WCWanyi Chen
Wanyi Chen

7 February 2024 in The American Journal of Tropical Medicine and Hygiene
Verified
Journal Article
Closed access
PDF file
HBHao Bai
Hao Bai
CLChao Li
Chao Li
XLXiangyu Lai
Xiangyu Lai
GHGang Xiao Hu
Gang Xiao Hu
LLLixian Li
Lixian Li
WCWanyi Chen
Wanyi Chen
: Fonsecaea monophora is a species of Fonsecaea that belongs to Chaetothyriales. It is usually isolated from tropical and subtropical regions, causing reactive inflammation, skin abscesses, and pain. Cerebral infection caused by F. monophora is rare but often fatal. Diagnosing this disease at an early stage is difficult, and appropriate antifungal therapy is often delayed as a result. We report the case of a 53-year-old woman with type 2 diabetes who presented with a headache 2 months ago and progressive right-sided weakness of 1 month’s duration. Magnetic resonance imaging revealed a space-occupying lesion in the left frontal lobe and corpus callosum. The cystic mass was removed by surgical intervention, and the identification of the sample based on sequencing of the internal transcribed spaced region in BLAST-N search showed that the sequences producing most significant alignments were F. monophora or similar (query cover 99%, E value 0.0, per ident 99.84). The patient was treated with a 3-month course of twice daily voriconazole, leading to complete recovery.

11 April 2025 in Pharmacological Reports
Verified
Journal Article
Closed access
PDF file
YCYa Chen
Ya Chen
SHSongling Han
Songling Han
XHXiaogang Hu
Xiaogang Hu
XMXue Ma
Xue Ma
YQYue Qiu
Yue Qiu
WCWanyi Chen
Wanyi Chen